Denvax India is a pioneer in the field of personalized cancer immunotherapy, offering innovative dendritic cell-based treatment (DENVAX) that strengthens the body’s natural defense mechanism to fight cancer. Established in 2005 by Dr. Jamal A. Khan and Dr. Sharmin Yaqin, Denvax has over 25 years of clinical experience in developing advanced cellular immunotherapy solutions for cancer patients across India. The Denvax treatment involves using a patient’s immune cells, processed into dendritic cells, which are then administered back into the body to recognize and destroy cancer cells. Website: https://www.denvaxindia.com/
Contact Us
Address: 18 Poorvi Marg Vasant Vihar, New Delhi 110057 India
